Bio-Rad Laboratories Total Assets 2006-2019 | BIO

Bio-Rad Laboratories total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bio-Rad Laboratories total assets for the quarter ending March 31, 2019 were $6.863B, a 10.43% increase year-over-year.
  • Bio-Rad Laboratories total assets for 2018 were $5.611B, a 31.31% increase from 2017.
  • Bio-Rad Laboratories total assets for 2017 were $4.273B, a 10.97% increase from 2016.
  • Bio-Rad Laboratories total assets for 2016 were $3.851B, a 3.8% increase from 2015.
Bio-Rad Laboratories Annual Total Assets
(Millions of US $)
2018 $5,611
2017 $4,273
2016 $3,851
2015 $3,710
2014 $3,341
2013 $3,389
2012 $3,444
2011 $3,097
2010 $3,063
2009 $2,536
2008 $2,037
2007 $1,972
2006 $1,596
2005 $1,427
Bio-Rad Laboratories Quarterly Total Assets
(Millions of US $)
Q1 2019 $6,863
Q4 2018 $5,611
Q3 2018 $6,719
Q2 2018 $6,386
Q1 2018 $6,215
Q4 2017 $4,273
Q3 2017 $4,186
Q2 2017 $4,143
Q1 2017 $3,953
Q4 2016 $3,851
Q3 2016 $4,020
Q2 2016 $3,875
Q1 2016 $3,753
Q4 2015 $3,710
Q3 2015 $3,666
Q2 2015 $3,525
Q1 2015 $3,326
Q4 2014 $3,341
Q3 2014 $3,386
Q2 2014 $3,468
Q1 2014 $3,441
Q4 2013 $3,389
Q3 2013 $3,280
Q2 2013 $3,483
Q1 2013 $3,457
Q4 2012 $3,444
Q3 2012 $3,303
Q2 2012 $3,169
Q1 2012 $3,188
Q4 2011 $3,097
Q3 2011 $2,970
Q2 2011 $3,044
Q1 2011 $2,909
Q4 2010 $3,063
Q3 2010 $2,682
Q2 2010 $2,527
Q1 2010 $2,547
Q4 2009 $2,536
Q3 2009 $2,478
Q2 2009 $2,344
Q1 2009 $1,955
Q4 2008 $2,037
Q3 2008 $2,015
Q2 2008 $2,099
Q1 2008 $2,053
Q4 2007 $1,972
Q3 2007 $1,712
Q2 2007 $1,655
Q1 2007 $1,607
Q4 2006 $1,596
Q3 2006 $1,524
Q2 2006 $1,494
Q1 2006 $1,415
Q4 2005 $1,427
Q3 2005 $1,426
Q2 2005 $1,393
Q1 2005 $1,399
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.194B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.296B 28.49
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
Baxter (BAX) United States $42.165B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
Smith & Nephew SNATS (SNN) United Kingdom $19.113B 0.00
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.254B 51.05
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Quidel (QDEL) United States $2.261B 23.46
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00